Skip to content

Comparison of Bicitra and Polycitra in treatment of children with urolithiasis

Comparison of Bicitra and Polycitra in treatment of children urolithiasis refered to Hazrat Masoumeh hospital, Qom

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190619043945N1
Enrollment
176
Registered
2020-03-16
Start date
2020-04-08
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary stones.

Interventions

Intervention 1: Intervention group: Bicitra
which involve citric acid and sodium in powder form, soluble in water or juice and is administered orally in half to one and a half mg daily in three doses.This drug should be taken within six month
which involve citric acid and potasium in powder form, soluble in water or juice and is administered orally in half to one and a half mg daily in three doses.This drug should be taken within six mon

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: 5-18 years old children with urinary tract stones No underlying disease Informed consent 3-5 mm urinary stones Hypocitratory in urine analysis Negative urine culture

Exclusion criteria

Exclusion criteria: Patient non- cooperation Patient dissatisfaction having underlying disease No medication that may interfere with our treatment

Design outcomes

Primary

MeasureTime frame
Size of urinary stones. Timepoint: At the beginning of study; 3 and 6 months after treatment. Method of measurement: Ultrasound and Kidney Urinary tract Bladder Grafey.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Razavi

Ghoum University of Medical Sciences

dfm_medical@yahoo.com+98 25 3874 9199

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026